For Ever has entered into a strategic partnership with Synergia Capital Partners
For Ever, the global market leader in gladiolus breeding, has entered into a strategic partnership with Synergia Capital Partners B.V. With this investment, the company will continue the strong growth of recent years.
Based in the Netherlands, For Ever was established in 1998, when three gladiolus breeders brought their genetics into one company. The merger aimed to create economies of scale, which has resulted in the company’s current dominant position in the sector. Breeding is the process of developing and producing new plant species. For Ever has developed unique gladiolus varieties that are appreciated by its customers all over the world. On the back of its number one position, For Ever is well positioned to benefit from the current market dynamics and increase its market share.
Synergia Capital Partners is an investment company funded by successful Dutch entrepreneurs which invests in companies based on the premise that a combination of knowledge and capital will lead to success. One of their focus sectors is agriculture, and with a strong track record within the space, Synergia is believed to have the right capabilities and experience to support For Ever in realizing its strategic goals.
Oaklins’ team in the Netherlands served as the exclusive sell-side advisors to For Ever in this transaction.



Theo van Aanholt
Director, For Ever
Talk to the deal team


Casper Oude Essink
Associate Director
Amsterdam, NetherlandsOaklins Netherlands
Related deals
Capricorn Holding has been acquired by Forster Gruppe and Genossenschaft Migros Aare
The owners of Capricorn Holding AG have sold the company to Forster Gruppe AG and Genossenschaft Migros Aare, optimal buyers that will guarantee the continuation of the business in the future. The three parties have agreed not to disclose any financial information about the transaction.
Learn moreAce Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.
Learn moreArgon Corporation has been acquired by Spectra
The private shareholders of Argon Corporation have sold the company to Spectra Aerospace and Defense, LLC (Spectra), a platform formed by Vance Street Capital.
Learn more